These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2861562

  • 21. Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes.
    Korelitz BI, Sommers SC.
    Am J Gastroenterol; 1975 Nov; 64(5):365-70. PubMed ID: 2008
    [Abstract] [Full Text] [Related]

  • 22. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D, Mantellini P, Calabrò A, Panerai C, Amorosi A, Paladini I, Salvadori G, Garcea MR, Surrenti C.
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [Abstract] [Full Text] [Related]

  • 23. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 24. [The development of histological findings in the rectum in ulcerative colitis during therapy].
    Cheli R.
    Cesk Gastroenterol Vyz; 1967 Sep; 21(6):353-5. PubMed ID: 5006601
    [No Abstract] [Full Text] [Related]

  • 25. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
    D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR.
    Gastroenterology; 2007 Feb; 132(2):763-86. PubMed ID: 17258735
    [No Abstract] [Full Text] [Related]

  • 26. [Morphological changes in the colonic mucosa in nonspecific ulcerative colitis (according to aspiration biopsy data)].
    Zabelina TN.
    Ter Arkh; 1966 May; 38(5):86-93. PubMed ID: 5991936
    [No Abstract] [Full Text] [Related]

  • 27. [ Ulcerative colitis and pregnancy].
    Flechsig U, Richter P, Seidel H.
    Zentralbl Gynakol; 1989 May; 111(16):1128-31. PubMed ID: 2573223
    [Abstract] [Full Text] [Related]

  • 28. Intestinal mucosa-associated microflora in ulcerative colitis patients before and after restorative proctocolectomy with an ileoanal pouch.
    Almeida MG, Kiss DR, Zilberstein B, Quintanilha AG, Teixeira MG, Habr-Gama A.
    Dis Colon Rectum; 2008 Jul; 51(7):1113-9. PubMed ID: 18483827
    [Abstract] [Full Text] [Related]

  • 29. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I, Kawasaki M, Nagahama S, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
    [Abstract] [Full Text] [Related]

  • 30. [The effect of salazosulfapyridine on fertility].
    Malchow H.
    Z Gastroenterol Verh; 1981 Jun; 19():21-3. PubMed ID: 6168127
    [No Abstract] [Full Text] [Related]

  • 31. Long-term study of the effect of treatment for ulcerative colitis.
    Henrikson B, Hultén L, Filipson S, Sillĕn U.
    Prog Pediatr Surg; 1978 Jun; 11():27-39. PubMed ID: 24233
    [No Abstract] [Full Text] [Related]

  • 32. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, Safdi M.
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [Abstract] [Full Text] [Related]

  • 33. Current concepts of colitis. 1.
    Morson B.
    Trans Med Soc Lond; 1970 Aug; 86():159-76. PubMed ID: 4924351
    [No Abstract] [Full Text] [Related]

  • 34. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 35. [Radiographic changes in the chest in a patient with ulcerative colitis treated with salazosulfapyridine].
    Wellnitz H, Christensen T.
    Ugeskr Laeger; 1985 Jul 08; 147(28):2235-6. PubMed ID: 2865837
    [No Abstract] [Full Text] [Related]

  • 36. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
    Xu J, Tam M, Samaei S, Lerouge S, Barralet J, Stevenson MM, Cerruti M.
    Acta Biomater; 2017 Jan 15; 48():247-257. PubMed ID: 27769943
    [Abstract] [Full Text] [Related]

  • 37. [Intestinal mucosa protection of muscovite n ulcerative colitis in rats].
    Wang LJ, Chen SJ, Si JM.
    Zhongguo Zhong Yao Za Zhi; 2005 Dec 15; 30(23):1840-4. PubMed ID: 16499023
    [Abstract] [Full Text] [Related]

  • 38. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F.
    Am J Gastroenterol; 1997 Nov 15; 92(11):2001-6. PubMed ID: 9362180
    [Abstract] [Full Text] [Related]

  • 39. [Salazosulfapyridine or 5-aminosalicylic acid].
    van Hees PA.
    Ned Tijdschr Geneeskd; 1987 May 30; 131(22):931-4. PubMed ID: 2885762
    [No Abstract] [Full Text] [Related]

  • 40. "Ulcerative appendicitis" occurring as a skip lesion in chronic ulcerative colitis; report of a case.
    Cohen T, Pfeffer RB, Valensi Q.
    Am J Gastroenterol; 1974 Aug 30; 62(2):151-5. PubMed ID: 4855480
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.